پیوندهای مفید
آمار
| تعداد نشریات | 20 |
| تعداد شمارهها | 1,149 |
| تعداد مقالات | 10,518 |
| تعداد مشاهده مقاله | 45,415,640 |
| تعداد دریافت فایل اصل مقاله | 11,291,439 |
The Role of T Regulatory Lymphocytes in Lymphoma | ||
| Middle East Journal of Cancer | ||
| مقاله 2، دوره 5، شماره 2، تیر 2014، صفحه 55-66 اصل مقاله (792.77 K) | ||
| نوع مقاله: Review Article(s) | ||
| نویسندگان | ||
| Ahmad Nasser1، 2؛ Afra Khosravi* 3؛ Reza Azizian1 | ||
| 1Student Research Committee, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran | ||
| 2Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran | ||
| 3Immunology Department, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran | ||
| چکیده | ||
| T regulatory cells play a crucial role in immunological unresponsiveness to self- antigens and in suppressing excessive immune responses deleterious to the host. T regulatory cells are produced in the thymus as a functionally mature subpopulation of T cells. They can be induced from naive T cells in the periphery and express their marker as a forkhead/winged helix transcription factor called FoxP3. In patients with lymphomas where T regulatory cells serve as suppressor anti-tumor cytotoxicity, decreased numbers of T regulatory cells are associated with a favorable prognosis. In contrast, in patients with lymphomas where T regulatory cells function as anti-tumor cytotoxic agents, enhanced numbers of T regulatory cells are associated with a favorable prognosis. Tumors actively promote the accumulation of these cells through several mechanisms that involve activation of naturally occurring T regulatory cells as well as conversion of non-T regulatory cells into T regulatory cells. Tumor-derived prostaglandin E2 can increase T regulatory cell activity and induce a regulatory phenotype in CD4+CD25+T cells. On the other hand, a balance between T regulatory and Th17 cells is essential for maintaining homeostasis of anti-tumor immunity. Accelerating processes such as increasing the amounts of IL-6 or IL-17 can enhance FoxP3 T regulatory cell expression and result in a lymphoma or inactivation of T cell CD4+. This effect is the reason for malignancy and a reduction in anti-tumor immune response. In this systematic review we intend to analyze this relationship. We have collected and analyzed the majority of recently published articles on the role of T regulatory cells as a review article. | ||
|
آمار تعداد مشاهده مقاله: 4,439 تعداد دریافت فایل اصل مقاله: 939 |
||